Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06101030 · ClinicalTrials.gov registry record

Comparing Use of Incentive Spirometry With and Without Reminder

A clinical trial of Post Operative, sponsored by Tidal Medical Technologies.

Recruiting
Registry status
500
Enrollment target
3
Study locations

NCT06101030: Recruiting study of Post Operative, sponsored by Tidal Medical Technologies.

NCT06101030 is a study of Post Operative that is actively recruiting participants, run by Tidal Medical Technologies. The registered enrollment target is 500 participants, below the 661-participant average among 3 other Post Operative trials with a reported enrollment target (24% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06101030, a study of Post Operative, is actively recruiting participants, sponsored by Tidal Medical Technologies.

RECRUITING
Registry status
500 participants
Enrollment target
3
Study locations

Study Summary

This study is designed to determine if patients using an incentive spirometer with visual and auditory signals will increase their use of the incentive spirometer and prevent lung complications.

Primary Outcome

successful inspiratory breaths is defined as achieving the goal tidal volume

Conditions Studied

Interventions

  • DEVICE Signal On

Study Locations (3)

Maryland

  • Tidal Reseach Site - Silver Spring

Minnesota

  • Tidal Study Site - Rochester

New Jersey

  • Tidal Study Site - New Brunswick

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2024-01-16
Est. Completion 2025-09-07
Tidal Medical Technologies

1 total trials

What NCT06101030 shows while recruiting

NCT06101030 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 661-participant average among 3 other Post Operative trials with a reported enrollment target (24% lower).

The record links to 1 condition, with Post Operative appearing as the primary indexed condition, and to 1 intervention - of which Signal On is the first listed.

NCT06101030 reports a single indexed study location in Maryland, Minnesota, New Jersey.

Frequently Asked Questions

What is clinical trial NCT06101030 about?

NCT06101030 is a clinical study titled "Comparing Use of Incentive Spirometry With and Without Reminder". This study is designed to determine if patients using an incentive spirometer with visual and auditory signals will increase their use of the incentive spirometer and prevent lung complications.

What is the current status of trial NCT06101030?

This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2024-01-16. Estimated completion is 2025-09-07.

What conditions does trial NCT06101030 study?

This clinical trial studies the following conditions: Post Operative.

What interventions are being tested in trial NCT06101030?

The interventions under investigation include: Signal On (DEVICE).

Who is sponsoring clinical trial NCT06101030?

This trial is sponsored by Tidal Medical Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06101030 being conducted?

This trial has 3 study locations across Maryland, Minnesota, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post Operative

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06101030, the US trial registry maintained by the National Library of Medicine. NCT06101030 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.